How useful is contrast enhanced ultrasonography for the characterization of focal liver lesions?

Journal of Gastrointestinal and Liver Diseases

Volumn 19, Issue 4, 2010, Pages 393-398

  Sporea, Ioan ^a   Sirli, Roxana ^a   Martie, Alina ^a   Popescu, Alina ^a   Danila, Mirela ^a  

^a VICTOR BABES UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

Author keywords

Contrast agent; Contrast enhanced ultrasound; Focal liver lesions; Liver cirrhosis

Indexed keywords

ADULT; AGED; ARTICLE; CHRONIC HEPATITIS; CHRONIC LIVER DISEASE; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DIAGNOSTIC IMAGING; DISEASE SEVERITY; FEMALE; HUMAN; LIVER CIRRHOSIS; LIVER INJURY; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRACTICE GUIDELINE; PROSPECTIVE STUDY; BIOPSY; ECHOGRAPHY; LIVER DISEASE; LIVER TUMOR; MIDDLE AGED; PREDICTIVE VALUE; ROMANIA;

CONTRAST AGENT BR1; CONTRAST MEDIUM; DIAGNOSTIC AGENT; PHOSPHOLIPID; SULFUR HEXAFLUORIDE;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY; CONTRAST MEDIA; FEMALE; HUMANS; LIVER DISEASES; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PHOSPHOLIPIDS; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; ROMANIA; SULFUR HEXAFLUORIDE; TOMOGRAPHY, X-RAY COMPUTED; YOUNG ADULT;

EID: 79952466165     PISSN: 18418724     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Albrecht T, Blomley M, Bolondi L, et al. EFSUMB Study Group. Guidelines for the use of contrast agents in ultrasound. Ultraschall Med 2004;25:249-256.
2. Claudon M, Cosgrove D, Albrecht T, et al. Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS)-update 2008. Ultraschall Med 2008;29:28-44.
3. Strobel D, Seitz K, Blank W, et al. Contrast-enhanced ultrasound for the characterization of focal liver lesions-diagnostic accuracy in clinical practice (DEGUM multicenter trial). Ultraschall Med 2008;29:499-505.
4. Tranquart F, Le Gouge A, Correas JM, et al. Role of contrast-enhanced ultrasound in the blinded assessment of focal lesions in comparison with MDCT and CEMRI: Results from a multicentre clinical trial. Eur J Cancer 2008; suppl 6:9-15.
5. Seitz K, Strobel D, Bernatik T, A et al. Contrast-Enhanced Ultrasound (CEUS) for the characterization of focal liver lesions-prospective comparison in clinical practice: CEUS vs. CT (DEGUM multicenter trial). Ultraschall Med 2009; 30: 383-389.
6. Braun B. Focal liver processes: "better is the enemy of good": CEUS in the fast lane. Ultraschall Med 2009; 30: 329-332.
7. Wilson SR, Greenbaum LD, Goldberg BB. Contrast-enhanced ultrasound: what is the evidence and what are the obstacles? AJR Am J Roentgenol 2009;193:55-60.
8. Sporea I, Şirli R, Deleanu A, et al. Acoustic Radiation Force Impulse elastography as compared to transient elastography and liver biopsy in patients with chronic hepatopathies. Ultraschall Med 2010 Jul 5.
9. Sporea I, Badea R, Şirli R, et al. Usefulness of real time-elastography (Siemens) for the evaluation of liver stiffness. Gut 2009; 58 (suppl II): A503.
10. Friedrich-Rust M, Wunder K, Kriener S, et al. Liver fibrosis in viral hepatitis: noninvasive assessment with acoustic radiation force impulse imaging versus transient elastography. Radiology 2009;252:595-604.
11. Wang WP, Wu Y, Luo Y, et al. Clinical value of contrast-enhanced ultrasonography in the characterization of focal liver lesions: a prospective multicenter trial. Hepatobiliary Pancreat Dis Int 2009; 4: 370-376.
12. Trillaud H, Bruel JM, Valette PJ, et al. Characterization of focal liver lesions with SonoVue-enhanced sonography: international multicenter-study in comparison to CT and MRI. World J Gastroenterol 2009; 15: 3748-3756.
13. Quaia E, Calliada F, Bertolotto M, et al. Characterization of focal liver lesions with contrast-specific US modes and a sulfur hexafluoride-filled microbubble contrast agent: diagnostic performance and confidence. Radiology 2004;232:420-430.
14. von Herbay A, Vogt C, Willers R, Häussinger D. Real-time imaging with the sonographic contrast agent SonoVue: differentiation between benign and malignant hepatic lesions. J Ultrasound Med 2004;23:1557-1568.
15. Strobel D, Seitz K, Blank W, et al. Tumor-specific vascularization pattern of liver metastasis, hepatocellular carcinoma, hemangioma and focal nodular hyperplasia in the differential diagnosis of 1,349 liver lesions in contrast-enhanced ultrasound (CEUS). Ultraschall Med 2009;30:376-378.
16. Seitz K, Bernatik T, Strobel D, et al. Contrast-Enhanced Ultrasound (CEUS) for the characterization of focal liver lesions in clinical practice (DEGUM Multicenter Trial): CEUS vs. MRI-a prospective comparison in 269 Patients. Ultraschall Med 2010 Jul 22.
17. Tranquart F, Correas JM, Ladam Marcus V, et al. Echographie de contraste temps reel dans la prise en charge diagnostique des lesions nodulaires hepatiques: evaluation des performances diagnostiques et de l'impact economique sur une etude multicentrique francaise. J Radiol 2009; 90: 109-122.
18. Romanini L, Passamonti M, Aiani L, et al. Economic assessment of contrast-enhanced ultrasonography for evaluation of focal liver lesions: a multicentre Italian experience. Eur Radiol 2007;17 Suppl 6:F99-106.
19. Giesel FL, Delorme S, Sibbel R, Kauczor HU, Krix M. Contrast-enhanced ultrasound for the characterization of incidental liver lesions-an economical evaluation in comparison with multi-phase computed tomography. Ultraschall Med 2009;30:259-268.
20. Piscaglia F, Bolondi L; Italian Society for Ultrasound in Medicine and Biology (SIUMB) Study Group on Ultrasound Contrast Agents. The safety of SonoVue in abdominal applications: retrospective analysis of 23188 investigations. Ultrasound Med Biol 2006;32:1369-1375.
21. Geleijnse ML, Nemes A, Vletter WB, et al. Adverse reactions after the use of sulphur hexafluoride (SonoVue) echo contrast agent. J Cardiovasc Med 2009;10:75-77.